CN Patent

CN108350455A — 用于使b型肝炎病毒基因表达沉默的组合物和方法

Assigned to Abt J Biopharmaceutical Co · Expires 2018-07-31 · 8y expired

What this patent protects

本发明提供包含靶向B型肝炎病毒(HBV)基因表达的诸如siRNA等治疗性核酸的组合物、包含所述治疗性核酸中的一种或多种(例如组合)的脂质粒子以及递送和/或施用所述脂质粒子(例如用于治疗人类的HBV感染和/或HDV感染)的方法。

USPTO Abstract

本发明提供包含靶向B型肝炎病毒(HBV)基因表达的诸如siRNA等治疗性核酸的组合物、包含所述治疗性核酸中的一种或多种(例如组合)的脂质粒子以及递送和/或施用所述脂质粒子(例如用于治疗人类的HBV感染和/或HDV感染)的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN108350455A
Jurisdiction
CN
Classification
—
Expires
2018-07-31
Drug substance claim
No
Drug product claim
No
Assignee
Abt J Biopharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.